AI Summary

The author runs a medical practice that treats obesity primarily via video consultations, handling labs, patient history and follow‑up entirely through telemedicine. They argue that effective telemedicine requires strict standards and that the FDA should begin enforcing those standards. Specifically, they call for the agency to target online sellers, stand‑in prescribers and other bad actors who misuse compounding regulations to exploit patients. The piece urges a crackdown on these practices to protect the integrity of telehealth obesity treatment.

AI summaries can be wrong sometimes—always verify important details using the source article.